Apple CEO Tim Cook told CNBC in a statement shared on live television that Apple has no intention to license Masimo’s patents. While it seemed likely that was the case, the company hadn’t said as much publicly until now.
“We’re focused on appeal,” Cook’s statement said. “There’s lots of reasons to buy the watch even without the blood oxygen sensor.”
Furthermore, licensing a patent can give credibility to said patent, making it more difficult to prove in court that it was ever invalid in the first place.